About This Fund
Dent&Co, a fund launched by Miura Partners, has raised over €200 million from international institutional investors. The fund is specifically targeted to back Proclinic Group, a leading dental distribution company in Europe, in its next phase of growth and consolidation through acquisitions. Proclinic Group, headquartered in Zaragoza, Spain, is a leading pan-European integrated provider of solutions for the dental sector with a strong omnichannel presence in key European markets. The company offers a broad product portfolio of dental consumables and equipment, as well as value-added services such as after-sales training, technical support, and digitalization. Dent&Co aims to further develop the growth plan of Proclinic Group by reinforcing the commercial strategy, expanding products and services, integrating new acquisitions, and exploring new M&A opportunities in other European countries. The fund's investment in Proclinic Group has already driven important value-generating initiatives, including management reinforcement, strategic acquisitions in key geographies and new business lines, commitment to digitalization, investment in leading logistics platforms, and sustainability initiatives. With annual sales reaching €256 million in 2023 and an annual growth of 29% since 2020, Proclinic Group represents a well-invested and differentiated platform with a proven ability to execute growth. Overall, Dent&Co targets investments in small and medium-sized family-owned and entrepreneurial companies within the dental sector in Europe, with a clear focus on sustainability. "